Aurora Cannabis Refutes Curaleaf's Bid Undervalues Company
Aurora Cannabis has responded to Curaleaf's latest announcement, stating it's a desperate attempt to distract shareholders from the core issue: Curaleaf's hostile bid undervalues Aurora.
Aurora Cannabis has dismissed Curaleaf's recent announcement as a "desperate effort" to divert attention from what Aurora considers the fundamental issue facing shareholders: Curaleaf's inadequate hostile bid undervalues Aurora.
The company stated that Curaleaf's attempt to fabricate issues ignores the reality of its own balance sheet, citing Curaleaf's debt exceeding $1 billion and questioning its long-term operational capacity.
This exchange comes as Curaleaf continues its pursuit of Aurora, highlighting a disagreement over the valuation of Aurora Cannabis. Aurora's stance suggests a belief that the current offer does not reflect its intrinsic worth.
The situation underscores a critical valuation gap between the two cannabis companies, with Aurora Cannabis actively resisting what it deems an unfair acquisition offer from its competitor.